- Home
- ACRV vs SRFM Comparison
ACRV vs SRFM Comparison
Compare ACRV & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- SRFM
- Stock Information
- Founded
- ACRV 2018
- SRFM 2011
- Country
- ACRV United States
- SRFM United States
- Employees
- ACRV N/A
- SRFM N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- SRFM Transportation Services
- Sector
- ACRV Health Care
- SRFM Consumer Discretionary
- Exchange
- ACRV Nasdaq
- SRFM Nasdaq
- Market Cap
- ACRV 59.9M
- SRFM 58.2M
- IPO Year
- ACRV 2022
- SRFM 2023
- Fundamental
- Price
- ACRV $1.16
- SRFM $2.68
- Analyst Decision
- ACRV Strong Buy
- SRFM Strong Buy
- Analyst Count
- ACRV 5
- SRFM 3
- Target Price
- ACRV $19.75
- SRFM $6.02
- AVG Volume (30 Days)
- ACRV 1.3M
- SRFM 95.8K
- Earning Date
- ACRV 05-20-2025
- SRFM 05-13-2025
- Dividend Yield
- ACRV N/A
- SRFM N/A
- EPS Growth
- ACRV N/A
- SRFM N/A
- EPS
- ACRV N/A
- SRFM N/A
- Revenue
- ACRV N/A
- SRFM $119,425,000.00
- Revenue This Year
- ACRV N/A
- SRFM N/A
- Revenue Next Year
- ACRV N/A
- SRFM $45.73
- P/E Ratio
- ACRV N/A
- SRFM N/A
- Revenue Growth
- ACRV N/A
- SRFM 97.38
- 52 Week Low
- ACRV $1.30
- SRFM $0.90
- 52 Week High
- ACRV $10.29
- SRFM $6.72
- Technical
- Relative Strength Index (RSI)
- ACRV 28.93
- SRFM 52.36
- Support Level
- ACRV $1.32
- SRFM $2.34
- Resistance Level
- ACRV $1.50
- SRFM $2.55
- Average True Range (ATR)
- ACRV 0.17
- SRFM 0.15
- MACD
- ACRV 0.06
- SRFM 0.06
- Stochastic Oscillator
- ACRV 1.55
- SRFM 82.35
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.